Myocardial Protection: The Efficacy of an Ultra-Short-Acting Β-Blocker, Esmolol, as a Cardioplegic Agent

Journal of Thoracic and Cardiovascular Surgery - United States
doi 10.1067/mtc.2001.115919
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ultra-Short-Acting Relaxants

BMJ
1952English

Myocardial Protection Against Global Ischemia With Krebs-Henseleit Buffer-Based Cardioplegic Solution

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2013English

Effect of Short-Acting Beta Blocker on the Cardiac Recovery After Cardiopulmonary Bypass

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2011English

Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2016English

The Long-Acting Ca2+-Channel Blocker Azelnidipine Prevents Left Ventricular Remodeling After Myocardial Infarction

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2007English

What Are the Benefits of Short-Acting Β-Blockers for Perioperative Management?

THE JOURNAL OF JAPAN SOCIETY FOR CLINICAL ANESTHESIA
2011English

Bolus Administration of Esmolol for the Treatment of Intraoperative Myocardial Ischaemia

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1989English

Efficacy of Lepidium Sativum to Act as an Anti-Diabetic Agent

Progress in Health Sciences
2017English

Interaction of an Ultra-Short Laser Pulse and Ultra-Intense With a Dielectric

American Journal of Nanosciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy